G-5758

N/A

Report date: 2024/05/21 17:40:23
NME

Base Information

Drug NameG-5758
Drug Alias NameG-5758
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase/endoribonuclease IRE1 inhibitors
TargetsSerine/threonine-protein kinase/endoribonuclease IRE1
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGenentech IncParaza Pharma IncWuxi Apptec Co Ltd +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesParaza Pharma IncViva Biotech HoldingsGenentech Inc +[4] 
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A